| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/10/2004 | WO2004047854A2 Methods for the treatment of alzheimers disease and compositions therefore |
| 06/10/2004 | WO2004047853A2 Methods for the treatment of chronic pain and compositions therefor |
| 06/10/2004 | WO2004047812A1 Hollow nanoparticles of protein and drug using the same |
| 06/10/2004 | WO2004047767A2 Methods for identifying risk of breast cancer and treatments thereof |
| 06/10/2004 | WO2004047762A2 Methods for treating cancer using porimin as a target |
| 06/10/2004 | WO2004047758A2 Methods of therapy and diagnosis using targeting of cells that express p2y10 |
| 06/10/2004 | WO2004047740A2 Composition and method for treating lupus nephritis |
| 06/10/2004 | WO2004047728A2 Compositions and methods for the treatment of immune related diseases |
| 06/10/2004 | WO2004047623A2 Methods for identifying risk of breast cancer and treatments thereof |
| 06/10/2004 | WO2004047530A1 Transgenic model expressing a prp gene homozygous for m129 |
| 06/10/2004 | WO2004047514A2 Methods for identifying risk of breast cancer and treatments thereof |
| 06/10/2004 | WO2004037202A9 Gb virus c and methods of treating viral infections |
| 06/10/2004 | WO2004035799A3 Viral vectors and the use of the same for gene therapy |
| 06/10/2004 | WO2004035092A3 Use of an agent modulating cofilin expresion or activity for the treatment of inflammatory diseases |
| 06/10/2004 | WO2004033717B1 Autism gene |
| 06/10/2004 | WO2004033672A3 Stem cell expansion factor blocking a gene limiting hox-induced expansion and method using such factor |
| 06/10/2004 | WO2004029576A3 Cell-based fluorescence resonance energy transfer (fret) assays for clostridial toxins |
| 06/10/2004 | WO2004029086A3 Regulation of human calcium-independent alpha-latrotoxin receptor homolog 3 |
| 06/10/2004 | WO2004024887A9 Centrosome proteins and uses thereof |
| 06/10/2004 | WO2004020468A3 Interferon beta-like molecules for treatment of cancer |
| 06/10/2004 | WO2004016793A3 Method of plastid transformation in asteraceae, vector for use therein and plants thus obtained |
| 06/10/2004 | WO2004013343A3 Use of lactobacillus to produce exopolysaccharides in food and pharmaceutical compositions |
| 06/10/2004 | WO2004013307A3 Compounds for targeting hepatocytes |
| 06/10/2004 | WO2004013285A3 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 06/10/2004 | WO2004011484A9 Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion |
| 06/10/2004 | WO2004005331A3 Peptides derived from pep133 (g1p3, 6-16) |
| 06/10/2004 | WO2004003145A3 Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds |
| 06/10/2004 | WO2004001425A3 Mhc class ii haplotype specific immunodominancy of peptides derived from rsv fusion (f) and attachement (g) proteins |
| 06/10/2004 | WO2003106632A3 Inhibitors of inflammatory gene activity and cholesterol biosynthesis |
| 06/10/2004 | WO2003104436A3 Cancer-linked gene as target for chemotherapy |
| 06/10/2004 | WO2003102140A3 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis |
| 06/10/2004 | WO2003095475A8 Peptide compounds and their use as protease substrates |
| 06/10/2004 | WO2003089571A3 Ehrlichia canis genes and vaccines |
| 06/10/2004 | WO2003087373A3 Production of recombinant fragments of muscle acetylcholine receptor and their use for ex vivo immunoadsorption of anti-ach receptor antibodies from myasthenic patients |
| 06/10/2004 | WO2003087158A3 Regulation of human transient receptor potential channel |
| 06/10/2004 | WO2003087157A9 Differentially expressed genes involved in angiogenesis, the proteins encoded thereby, and methods of using the same |
| 06/10/2004 | WO2003084472A3 Recombinant p. falciparum merozoite protein-142 vaccine |
| 06/10/2004 | WO2003083039A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/10/2004 | WO2003079995A3 Neisseria mutants, lipooligosaccharides and immunogenic compositions |
| 06/10/2004 | WO2003062469A3 Gene matn3 or matrilin-3 linked to osteoarthritis treatment |
| 06/10/2004 | WO2003060128A3 Compositions, methods and systems for discovery of lipopeptides |
| 06/10/2004 | WO2003060120A3 Means for identifying neisseiria menengitidis specific genes |
| 06/10/2004 | WO2003054755A3 Vaccine for periodontal disease |
| 06/10/2004 | WO2003054188A3 Seminal vesicle tissue-specific promoters and uses thereof |
| 06/10/2004 | WO2003054142A3 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| 06/10/2004 | WO2003039346A9 Diagnostics and therapeutics for ocular abnormalities |
| 06/10/2004 | WO2003037267B1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 06/10/2004 | WO2003026689A8 Autologous growth factor cocktail composition, method of production and use |
| 06/10/2004 | WO2003012121A3 Collagen xxii, a novel human collagen and uses thereof |
| 06/10/2004 | WO2003010329A3 Nucleic acid-associated proteins |
| 06/10/2004 | WO2003007800A9 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 06/10/2004 | WO2003004529A3 Ephrin-tie receptor materials and methods |
| 06/10/2004 | WO2003002606A3 Nucleic acids encoding ion channels |
| 06/10/2004 | WO2002094877A3 New nuclear receptor cofactors and related modulators |
| 06/10/2004 | WO2002090600A3 A method for regulating immune function in primates using the foxp3 protein |
| 06/10/2004 | WO2002090502A3 Highly conserved proteins from gram-positive bacteria |
| 06/10/2004 | WO2002057293B1 Modified zinc finger binding proteins |
| 06/10/2004 | WO2002040629A3 Promoters exhibiting endothelial cell specificity and methods of using same |
| 06/10/2004 | US20040111769 Sugar beet genes involved in stress tolerance |
| 06/10/2004 | US20040111768 Transcription factor stress-related proteins and methods of use in plants |
| 06/10/2004 | US20040111767 for maintaining homeostasis by sense or antisense expression of chimeric gene; genetic engineering |
| 06/10/2004 | US20040111766 for use as therapeutic agent or additive for ingestible food/feed |
| 06/10/2004 | US20040111764 expression cassette comprising promoter operably linked to a polynucleotide encoding a recombinational DNA repair polypeptide |
| 06/10/2004 | US20040111761 Sunflower anti-pathogenic proteins and genes and their uses |
| 06/10/2004 | US20040111758 Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene |
| 06/10/2004 | US20040111667 Human CCN-like growth factor |
| 06/10/2004 | US20040110941 by cloning, amplifying and expressing DNA sequences using polymerase chain reaction; for therapy, diagnosis or catalysis; solid phase synthesis |
| 06/10/2004 | US20040110940 Novel nucleic acids and polypeptides |
| 06/10/2004 | US20040110939 Complementary DNAs encoding proteins with signal peptides |
| 06/10/2004 | US20040110938 Comprises nucleotide sequences coding peptides for use in detection, screening and prognosis of psychological disorders and treatments |
| 06/10/2004 | US20040110937 Comprises nucleotide sequences coding signal transduction/transcriptional regulator for characterization, diagnosis, and treatment of cardiac and skeletal muscle disorders |
| 06/10/2004 | US20040110935 Universal carrier for targeting molecules to Gb3 receptor expressing cells |
| 06/10/2004 | US20040110934 Human mitochondrial proteins and polynucleotides encoding the proteins |
| 06/10/2004 | US20040110932 Comprises polypeptide agent of Class I cytokine receptor subfamily for prevention and treatment cell proliferation disorders; antitumor agents |
| 06/10/2004 | US20040110927 Expression vector coding secretory peptide antisense sequences for gene therapeutic treatment of tumors; antitumor agents |
| 06/10/2004 | US20040110925 Peptides from the E2, E6, and E7 proteins of human papilloma viruses 16 and 18 for detecting and/or diagnosing cervical and other human papillomavirus associated cancers |
| 06/10/2004 | US20040110924 Identification and characterization of multiple splice variants of the kappa3-related opioid receptor (KOR-3) gene |
| 06/10/2004 | US20040110923 Nucleic acid binding polypeptides |
| 06/10/2004 | US20040110922 Comprises nucleotide sequences coding viral envelope glycoprotein 120 for diagnosis, prevention and treatment of viral diseases; viricides |
| 06/10/2004 | US20040110921 Comprises chordin-like polypeptide fo diagnosis, pre vention and treatment of bone and cancer disorders; gene therapy; antitumor agents |
| 06/10/2004 | US20040110920 Novel g protein-coupled receptor protein and dna thereof |
| 06/10/2004 | US20040110919 Comprises toxic jellyfish protein for use as pesticide |
| 06/10/2004 | US20040110735 Methods of activating receptor using amphiphilic drug-oligomer conjugates |
| 06/10/2004 | US20040110730 Using salts of hydrazine and/or (thio)carbonylamino derivatives of hydrazine for conjugation and immobilization of biomolecules; diagnosis |
| 06/10/2004 | US20040110723 Modified psma ligands and uses related thereto |
| 06/10/2004 | US20040110716 Cancer gene therapy based on translational control of a suicide gene |
| 06/10/2004 | US20040110715 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 06/10/2004 | US20040110712 Methods for treating patients and identifying therapeutics |
| 06/10/2004 | US20040110711 Novel treatment of neurodegenerative diseases by altering levels of TrkB isoforms and/or TrkC isoforms |
| 06/10/2004 | US20040110706 Nucleic acid with point mutations, deletions, insertions and/or rearrangements ; hyperthermia, myasthenia, ataxia, neuropathic and inflammatory pain; Alzheimer*s, Parkinson's disease; schizophrenia, hyperekplexia, myotonias and arrhythmia |
| 06/10/2004 | US20040110684 Genetically engineered caveolin-; antiischemic, antitumor, and wound healing agents; cardiovascular and brain disorders |
| 06/10/2004 | US20040110683 Cell proliferation factor Fwa267 |
| 06/10/2004 | US20040110678 Novel drug delivery system |
| 06/10/2004 | US20040110677 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering |
| 06/10/2004 | US20040110675 Mutant human factor ix with an increased resistance to inhibition by heparin |
| 06/10/2004 | US20040110674 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer |
| 06/10/2004 | US20040110673 Treatment of diseases such as diabetes with administering CD83 and T-cells for medical diagnosis and proteins |
| 06/10/2004 | US20040110672 Genetic disorders and cholera endotoxins for calcium channel activators |
| 06/10/2004 | US20040110671 N-terminal modified recombinant human endostatin and its production |
| 06/10/2004 | US20040110670 Heterologous expression of neisserial proteins |